

1,401,948 filings since 2004 · latest accepted Nov 4, 2026, 6:23 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jun 29, 2022 accepted 12:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Apr 13, 2022 accepted 12:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jun 18, 2020 accepted 8:39 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Apr 24, 2020 accepted 9:15 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Apr 18, 2019 accepted 9:24 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 12, 2019 accepted 9:24 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.03Bylaws / fiscal year | DocumentSEC ↗ |
Dec 28, 2018 accepted 10:05 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Oct 18, 2018 accepted 9:12 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Feb 15, 2018 accepted 1:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Feb 8, 2018 accepted 1:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Jan 8, 2018 accepted 9:30 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Jul 28, 2017 accepted 1:17 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Jul 3, 2017 accepted 8:20 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 16, 2017 accepted 8:35 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Jun 8, 2017 accepted 9:04 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 11, 2017 accepted 9:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Dec 14, 2016 accepted 10:13 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Sep 29, 2016 accepted 12:45 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Dec 24, 2015 accepted 6:09 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement5.07Shareholder vote | DocumentSEC ↗ |
Dec 16, 2015 accepted 9:09 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 5, 2015 accepted 6:58 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Feb 6, 2015 accepted 6:22 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jun 25, 2014 accepted 12:38 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 24, 2014 accepted 9:12 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jan 13, 2014 accepted 12:00 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Jan 3, 2014 accepted 9:17 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Sep 13, 2013 accepted 9:35 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 27, 2013 accepted 9:10 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale | DocumentSEC ↗ |
Mar 11, 2013 accepted 8:53 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale | DocumentSEC ↗ |
Jan 28, 2013 accepted 9:28 PM ET | ATNMActinium Pharmaceuticals, Inc. | 8-K/A 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale4.01Auditor change5.01Change in control5.02Officer / director change5.05Code of ethics5.06Shell status change | DocumentSEC ↗ |
Jan 4, 2013 accepted 9:28 PM ET | ATNMActinium Pharmaceuticals, Inc. | 8-K/A 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale4.01Auditor change5.01Change in control5.02Officer / director change5.05Code of ethics5.06Shell status change | DocumentSEC ↗ |
Jan 2, 2013 accepted 10:33 PM ET | ATNMActinium Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale4.01Auditor change5.01Change in control5.02Officer / director change5.05Code of ethics5.06Shell status change | DocumentSEC ↗ |